| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/30/2002 | EP1175390A1 Disodium salts, monohydrates, and ethanol solvates |
| 01/30/2002 | EP1175257A1 Spray drying apparatus and methods of use |
| 01/30/2002 | EP1175220A2 Nanoparticulate eplerenone compositions |
| 01/30/2002 | EP1175218A1 Ocular therapy in keratoconjuctivitis sicca using topically applied androgens or tgf-beta |
| 01/30/2002 | EP1175216A2 Antimalarian agents for the treatment of asthma |
| 01/30/2002 | EP1175214A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 01/30/2002 | EP1175210A1 Increasing cerebral bioavailability of drugs |
| 01/30/2002 | EP1175207A1 Injection molding method for (meth)acrylate copolymers having tertiary ammonium groups |
| 01/30/2002 | EP1175206A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives |
| 01/30/2002 | EP1175205A2 Inhibitors of crystallization in a solid dispersion |
| 01/30/2002 | EP1175204A1 Aerosol formulations and devices for increasing libido in women via acute testosterone administration |
| 01/30/2002 | EP1175203A1 Folic acid supplement |
| 01/30/2002 | EP1175200A1 Use of nanoscalar antimicrobial active ingredients in body deodorants |
| 01/30/2002 | EP1173153A4 Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants |
| 01/30/2002 | EP1091746B1 Use of iso-osmotic saline solutions for preparing cerumenolytic medicines |
| 01/30/2002 | EP1045681A4 METHOD AND COMPOSITIONS FOR $i(IN SITU) FORMATION OF PROTECTIVE AND/OR MEDICATED FILMS ON BODY TISSUE |
| 01/30/2002 | EP0991409B1 Controlled release pharmaceutical compositions containing tiagabine |
| 01/30/2002 | EP0949908B1 Preparation consisting of a surface-adhering, film-like or wafer-like administration form |
| 01/30/2002 | EP0904050B1 Use of lactic acid esters |
| 01/30/2002 | EP0868183B1 Injectable quinolone formulations |
| 01/30/2002 | EP0857060B1 Method and preparations for stabilizing biological materials by drying methods without freezing |
| 01/30/2002 | EP0833621B1 Soft gelatin capsules containing particulate material |
| 01/30/2002 | EP0817620B1 Nanospheres comprising a biocompatible polysaccharide |
| 01/30/2002 | EP0814771B1 Improvements in or relating to organic compositions |
| 01/30/2002 | EP0744946B1 Compositions containing micronized nebivolol |
| 01/30/2002 | EP0707580B1 Magnesium omeprazole |
| 01/30/2002 | EP0614355B1 Antitumor vaccines |
| 01/30/2002 | EP0497922B1 Infective protein delivery system |
| 01/30/2002 | CN1333694A Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 01/30/2002 | CN1333690A Method for producing medicaments from plant extracts, in solid form of administration |
| 01/30/2002 | CN1333683A Pharmaceutical composition for modified release insulin sensitiser |
| 01/30/2002 | CN1333682A Storable active substance concentrate with formoterol |
| 01/30/2002 | CN1333681A Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood tribly cerides |
| 01/30/2002 | CN1333680A Oral formulation for gastrointestinal drug delivery |
| 01/30/2002 | CN1333679A Dispersible phospholipid stabilzed microparticles |
| 01/30/2002 | CN1333678A Hepatocyte targeting polyethylene glyco-grafted poly-lysine polymeric gene carrier |
| 01/30/2002 | CN1333677A Composition set and kit for use in intraocular surgery |
| 01/30/2002 | CN1333674A Flavour blend for masking unpleasant taste of zinc compounds |
| 01/30/2002 | CN1333651A Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method |
| 01/30/2002 | CN1333372A Process for preparing potide zinc easy absorbed in human body |
| 01/30/2002 | CN1333207A Sparfloxacin salt and synthesis method and use thereof |
| 01/30/2002 | CN1333058A Anti-impotence kidney-tonifying capsule |
| 01/30/2002 | CN1333049A Anti common cold chewing gum |
| 01/30/2002 | CN1333047A Yunnan pine nut extract and preparation process and use thereof |
| 01/30/2002 | CN1333046A Xiangshen injection and preparation process and use thereof |
| 01/30/2002 | CN1333045A Xiangshen soft capsule and preparation process and use thereof |
| 01/30/2002 | CN1333018A Medicine for treating immune relative disease of anterior chamber and surface of eye |
| 01/30/2002 | CN1078474C Snuff for treating mastopathy and its inhalator |
| 01/30/2002 | CN1078471C Health medicine for tonifying kidney and its production process |
| 01/30/2002 | CN1078468C Use of chlorophyll copper sodium salt making composition for anti gastric mucosa damage |
| 01/30/2002 | CN1078465C Skin-penetrating absorption prepration containing ondansetron |
| 01/30/2002 | CN1078464C Medicinal composition for preventing and curing xerophthalmia and disease led themby, method and apparatus |
| 01/30/2002 | CN1078462C Use of gossypol (and) its derivative as active component and use in preparation suppository in treating prostatitis |
| 01/30/2002 | CN1078461C Oestradiol transdermal therapeutic system comprising hydroscopic additives |
| 01/30/2002 | CN1078460C Program-controlled skin permeable plaster |
| 01/30/2002 | CN1078448C Stable, optically clear compositions |
| 01/29/2002 | US6342537 Gel for treatment of skin diseases and for disinfection of the skin |
| 01/29/2002 | US6342533 Antidepressants udes for bipolar and attention deficit disorders, hyperactivity, parkinson's disease, epilepsy, eating disorders |
| 01/29/2002 | US6342530 Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt |
| 01/29/2002 | US6342506 Camptothesin derivatives for antitumor agents with nitro or amino derivatives possible |
| 01/29/2002 | US6342493 Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
| 01/29/2002 | US6342478 Administering fibroblast growth factor through the nose |
| 01/29/2002 | US6342251 Compositions for nasal administration |
| 01/29/2002 | US6342250 Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
| 01/29/2002 | US6342249 Certain absorbent materials such as porous calcium hydrogen phosphate powders are used to deliver drugs in a liquid state |
| 01/29/2002 | US6342248 Dividable tablet and press-through pack |
| 01/29/2002 | US6342247 Pharmaceutical compositions containing irbesartan |
| 01/29/2002 | US6342246 Image forms and method for ameliorating male erectile dysfunction |
| 01/29/2002 | US6342245 Compositions of lipid lowering agents |
| 01/29/2002 | US6342244 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides, drugs and liposomes; upon cleavage of the linkage, the ligand |
| 01/29/2002 | US6342241 For sustained release the drug (b) to deliver it into an organism by a syringe, prevents irritation, inflammation |
| 01/29/2002 | US6342234 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 01/29/2002 | US6342226 Administering antigen combined with a particulate vector, the particulate vector consisting of a non-liquid hydrophilic core for increasing the immunogenicity of an antigen |
| 01/29/2002 | US6342224 For prophylaxis and therapy of human papilloma induced tumours |
| 01/29/2002 | US6342209 Cosmetic compositions containing film forming polymers plasticized with esters and malic acid |
| 01/29/2002 | US6342208 Oil-in-water emulsion containing C10-C24 fatty acid derivatives for treating skin of mammals |
| 01/29/2002 | US6342202 Injecting into blood vessel composition consisting essentially of polyvinyl acetate having molecular weight of at least about 50,000, contrast agent and biocompatible solvent to precipitate polymer and embolize blood vessel |
| 01/29/2002 | US6342051 Treatment of anoxic tissue with angiogenesis-inducing implants |
| 01/29/2002 | CA2222567C High viscosity liquid controlled biologically active delivery system |
| 01/29/2002 | CA2216789C Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
| 01/29/2002 | CA2207624C Selective and non-invasive visualization or treatment of vasculature |
| 01/29/2002 | CA2194555C Implanted device containing tumor cells for the treatment of cancer |
| 01/29/2002 | CA2132422C Method and device for treating a parenteral emulsion-containing medicament fluid |
| 01/29/2002 | CA2107568C Use of sphingolipids in the preparation of a cosmetic or dermato-pharmaceutical composition for the protection of skin and hair against the harmful effects of atmospheric pollution |
| 01/29/2002 | CA2093206C Biphasic release formulations for lipophilic drugs |
| 01/29/2002 | CA2066374C Solution for perfusing primates |
| 01/24/2002 | WO2002006507A1 Biodegradable articles obtained from enzymatically synthesized amylose |
| 01/24/2002 | WO2002006411A1 Use of heteroxylans for preparing film-forming compositions |
| 01/24/2002 | WO2002006373A1 Hydrogel films and methods of making and using therefor |
| 01/24/2002 | WO2002006349A1 Gel compositions containing metronidazole |
| 01/24/2002 | WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/24/2002 | WO2002005944A1 Method for encapsulating fine solid particles in the form of microcapsules |
| 01/24/2002 | WO2002005943A1 Method and device for making hollow polymeric particles containing substances of interest |
| 01/24/2002 | WO2002005870A2 Kits and compositions supporting intracranial perfusions |
| 01/24/2002 | WO2002005864A1 An implantable or insertable therapeutic agent delivery device |
| 01/24/2002 | WO2002005855A1 Pharmaceutical compositions containing dds compounds |
| 01/24/2002 | WO2002005853A2 Compositions containing alpha-2-adrenergic agonist components |
| 01/24/2002 | WO2002005852A1 Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| 01/24/2002 | WO2002005850A2 Enhancement of the action of anti-infective agents |
| 01/24/2002 | WO2002005848A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |